Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?

BACKGROUND: The benefits of some second-generation antipsychotics (SGAs) must be weighed against the increased risk for diabetes mellitus. This study examines whether the association between SGAs and diabetes differs by dose. METHODS: Patients were ≥18 years of age from three US healthcare systems a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulcickas Yood, Marianne, DeLorenze, Gerald N, Quesenberry, Charles P, Oliveria, Susan A, Tsai, Ai-Lin, Kim, Edward, Cziraky, Mark J, McQuade, Robert D, Newcomer, John W, L'Italien, Gilbert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264670/
https://www.ncbi.nlm.nih.gov/pubmed/22171594
http://dx.doi.org/10.1186/1471-244X-11-197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264670/
https://www.ncbi.nlm.nih.gov/pubmed/22171594
http://dx.doi.org/10.1186/1471-244X-11-197

Ejemplares similares